{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:41:00Z","timestamp":1791726060050,"version":"4.3.4"},"reference-count":79,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Tuberculosis (TB), an infection caused by Mycobacterium tuberculosis (Mtb), is one of the primary causes of death globally. The treatment of TB is long and based on several drugs, producing problems in compliance and toxicity, increasing Mtb resistance to first-line antibiotics that result in multidrug-resistant TB and extensively drug-resistant TB. Thus, the need for new anti-TB treatments has increased. Here, we review some model strategies to study gene therapy based on the administration of a recombinant adenovirus that encodes diverse cytokines, such as IFN\u03b3, IL12, GM\/CSF, OPN, TNF\u03b1, and antimicrobial peptides to enhance the protective immune response against Mtb. These models include a model of progressive pulmonary TB, a model of chronic infection similar to latent TB, and a murine model of pulmonary Mtb transmission to close contacts. We also review new vaccines that deliver Mtb antigens via particle- or virus-based vectors and trigger protective immune responses. The results obtained in this type of research suggest that this is an alternative therapy that has the potential to treat active TB as an adjuvant to conventional antibiotics and a promising preventive treatment for latent TB reactivation and Mtb transmission. Moreover, Ad vector vaccines are adequate for preventing infectious diseases, including TB.<\/jats:p>","DOI":"10.3390\/ph16101475","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:08:33Z","timestamp":1697530113000},"page":"1475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis"],"prefix":"10.3390","volume":"16","author":[{"given":"Dulce","family":"Mata-Espinosa","sequence":"first","affiliation":[{"name":"Secci\u00f3n de Patolog\u00eda Experimental, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga 15, Belisario Dom\u00ednguez Secci\u00f3n 16, Tlalpan, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6635-2939","authenticated-orcid":false,"given":"Jacqueline V.","family":"Lara-Espinosa","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Patolog\u00eda Experimental, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga 15, Belisario Dom\u00ednguez Secci\u00f3n 16, Tlalpan, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5134-5573","authenticated-orcid":false,"given":"Jorge","family":"Barrios-Pay\u00e1n","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Patolog\u00eda Experimental, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga 15, Belisario Dom\u00ednguez Secci\u00f3n 16, Tlalpan, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-3833","authenticated-orcid":false,"given":"Rogelio","family":"Hern\u00e1ndez-Pando","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Patolog\u00eda Experimental, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga 15, Belisario Dom\u00ednguez Secci\u00f3n 16, Tlalpan, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2150449","DOI":"10.1080\/21505594.2022.2150449","article-title":"Pathogenicity and virulence of Mycobacterium tuberculosis","volume":"14","author":"Rahlwes","year":"2023","journal-title":"Virulence"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1038\/s41598-023-38707-4","article-title":"Integer time series models for tuberculosis in Africa","volume":"13","author":"Ojo","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0300985811429313","article-title":"The Pathology of Mycobacterium tuberculosis Infection","volume":"49","author":"Sakamoto","year":"2012","journal-title":"Vet. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Poladian, N., Orujyan, D., Narinyan, W., Oganyan, A.K., Navasardyan, I., Velpuri, P., Chorbajian, A., and Venketaraman, V. (2023). Role of NF-\u03baB during Mycobacterium tuberculosis Infection. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021772"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The Immune Response in Tuberculosis","volume":"31","author":"Redford","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","unstructured":"World Health Organization (2021). Global Tuberculosis Report 2020: Synopsis [Global Tuberculosis Report 2020: Executive Summary], World Health Organization."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","article-title":"The status of tuberculosis vaccine development","volume":"20","author":"Schrager","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4236\/jtr.2015.34024","article-title":"Natural Remedies against Multi-Drug Resistant Mycobacterium tuberculosis","volume":"3","author":"Pandit","year":"2015","journal-title":"J. Tuberc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hameed, H.M.A., Islam, M.M., Chhotaray, C., Wang, C., Liu, Y., Tan, Y., Li, X., Tan, S., Delorme, V., and Yew, W.W. (2018). Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00114"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/17476348.2018.1457439","article-title":"The use of immunotherapy for the treatment of tuberculosis","volume":"12","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of gene therapy","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.mt.6300321","article-title":"Modification of adenovirus gene transfer vectors with synthetic polymers: A scientific review and technical guide","volume":"16","author":"Kreppel","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune Response to Mycobacterium tuberculosis: A Narrative Review","volume":"7","author":"Lodi","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Carabal\u00ed-Isajar, M.L., Rodr\u00edguez-Bejarano, O.H., Amado, T., Patarroyo, M.A., Izquierdo, M.A., Lutz, J.R., and Ocampo, M. (2023). Clinical manifestations and immune response to tuberculosis. World J. Microbiol. Biotechnol., 39.","DOI":"10.1007\/s11274-023-03636-x"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2217\/imt.13.111","article-title":"Immunotherapy for pulmonary TB: Antimicrobial peptides and their inducers","volume":"5","year":"2013","journal-title":"Immunotherapy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00005-009-0042-9","article-title":"Factors that deregulate the protective immune response in tuberculosis","volume":"57","author":"Orozco","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2006.08.003","article-title":"Endocrine and cytokine responses in humans with pulmonary tuberculosis","volume":"21","author":"Rook","year":"2007","journal-title":"Brain. Behav. Immun."},{"key":"ref_18","first-page":"26","article-title":"V Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis","volume":"89","author":"Orozcoe","year":"1996","journal-title":"Immunology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2567.1997.00193.x","article-title":"Analysis of the local kinetics and localization of interleukin-1\u03b1, tumour necrosis factor-\u03b1 and transforming growth factor-\u03b2, during the course of experimental pulmonary tuberculosis","volume":"90","author":"Orozco","year":"1997","journal-title":"Immunology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/506454","article-title":"\u0392-Defensin Gene Expression During the Course of Experimental Tuberculosis Infection","volume":"194","author":"Sada","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17476348.2021.1927718","article-title":"Extrapulmonary tuberculosis","volume":"15","author":"Sharma","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1148\/rg.2019190109","article-title":"Extrapulmonary tuberculosis: Pathophysiology and imaging findings","volume":"39","author":"Renjifo","year":"2019","journal-title":"Radiographics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2613.2000.00152.x","article-title":"Treatment with BB-94, A broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards Type-2 in experimental pulmonary tuberculosis in Balb\/c mice","volume":"81","author":"Orozco","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2249.2002.01832.x","article-title":"Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis","volume":"128","author":"Arriaga","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2008.03004.x","article-title":"Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model","volume":"128","author":"Robertson","year":"2009","journal-title":"Immunology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized Mouse Models of Clinical Disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Calderon, V.E., Valbuena, G., Goez, Y., Judy, B.M., Huante, M.B., Sutjita, P., Johnston, R.K., Estes, D.M., Hunter, R.L., and Actor, J.K. (2013). A Humanized Mouse Model of Tuberculosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063331"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"21522","DOI":"10.1038\/srep21522","article-title":"Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1","volume":"6","author":"Nusbaum","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fimmu.2019.00089","article-title":"Humanized mouse model mimicking pathology of human tuberculosis for in vivo evaluation of drug regimens","volume":"10","author":"Arrey","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_30","first-page":"729","article-title":"The Diagnosis and Treatment of Tuberculosis","volume":"116","author":"Rademacher","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20601","DOI":"10.2807\/1560-7917.ES2013.18.40.20601","article-title":"Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: Retrospective-prospective cohort study from 2004 to 2007","volume":"18","author":"Anderson","year":"2013","journal-title":"Eurosurveillance"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: Promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1002\/1873-3468.13687","article-title":"Adenoviruses across the animal kingdom: A walk in the zoo","volume":"593","author":"Harrach","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/bs.ircmb.2015.10.006","article-title":"Membrane Dynamics and Signaling of the Coxsackievirus and Adenovirus Receptor","volume":"322","author":"Loustalot","year":"2016","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1172\/JCI5309","article-title":"CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts","volume":"103","author":"Hidaka","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kulanayake, S., and Tikoo, S.K. (2021). Adenovirus core proteins: Structure and function. Viruses, 13.","DOI":"10.3390\/v13030388"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Garbuglia, A.R., Minosse, C., and Del Porto, P. (2022). mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People. Viruses, 14.","DOI":"10.3390\/v14040748"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Srivastava, S., Dey, S., and Mukhopadhyay, S. (2023). Vaccines against Tuberculosis: Where Are We Now?. Vaccines, 11.","DOI":"10.3390\/vaccines11051013"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune Responses to Viral Gene Therapy Vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gut.48.5.733","article-title":"The promise and potential hazards of adenovirus gene therapy","volume":"48","author":"Young","year":"2001","journal-title":"Gut"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00705-018-04132-6","article-title":"Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: A study on hamsters","volume":"164","author":"Melnikov","year":"2019","journal-title":"Arch. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/mt.2008.69","article-title":"Therapeutic effect of recombinant adenovirus encoding interferon-\u03b3 in a murine model of progressive pulmonary tuberculosis","volume":"16","author":"Rosales","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/hum.2022.030","article-title":"Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis","volume":"33","author":"Pando","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e12743","DOI":"10.1111\/sji.12743","article-title":"Immunotherapeutic effects of recombinant adenovirus encoding interleukin 12 in experimental pulmonary tuberculosis","volume":"89","author":"Bini","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon \u03b3 in resistance to mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.omtn.2020.10.023","article-title":"Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis","volume":"22","author":"Bharti","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102198","DOI":"10.1016\/j.tube.2022.102198","article-title":"Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis","volume":"134","author":"Bharti","year":"2022","journal-title":"Tuberculosis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00262-022-03144-1","article-title":"Interleukin-12 as an in situ cancer vaccine component: A review","volume":"71","author":"Cheng","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2567.2004.01904.x","article-title":"Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes","volume":"112","author":"Lambrecht","year":"2004","journal-title":"Immunology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cei.12015","article-title":"Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis","volume":"171","author":"Xing","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tube.2016.05.015","article-title":"Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis","volume":"100","author":"Xing","year":"2016","journal-title":"Tuberculosis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","article-title":"Osteopontin: Role in immune regulation and stress responses","volume":"19","author":"Wang","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/0929867321666140217110155","article-title":"Antimicrobial Peptides: Promising Compounds Against Pathogenic Microorganisms","volume":"21","author":"Cruz","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-3083.2008.02088.x","article-title":"The potential role of lung epithelial cells and \u03b2-defensins in experimental latent tuberculosis","volume":"67","author":"Contreras","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2010.04199.x","article-title":"Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis","volume":"161","author":"Serrano","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/JLB.4MA0920-627R","article-title":"Immunotherapeutic effect of adenovirus encoding antimicrobial peptides in experimental pulmonary tuberculosis","volume":"110","author":"Carretero","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"ftw075","DOI":"10.1093\/femspd\/ftw075","article-title":"Gene therapy based in antimicrobial peptides and pro-inflammatory cytokine prevents reactivation of experimental latent tuberculosis","volume":"74","author":"Carretero","year":"2016","journal-title":"Pathog. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1128\/IAI.73.9.5782-5788.2005","article-title":"Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs","volume":"73","author":"Happel","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ferreira, R.G., Gordon, N.F., Stock, R., and Petrides, D. (2021). Adenoviral vector covid-19 vaccines: Process and cost analysis. Processes, 9.","DOI":"10.3390\/pr9081430"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"895020","DOI":"10.3389\/fimmu.2022.895020","article-title":"Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Protective CD4 and CD8 T Cells within the Airway Lumen 1","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Xing, Z., McFarland, C.T., Sallenave, J.M., Izzo, A., Wang, J., and McMurray, D.N. (2009). Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005856"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/CVI.00275-12","article-title":"Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis","volume":"19","author":"Romera","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.vaccine.2019.10.102","article-title":"A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime\u2014MVA85A boost in healthy UK adults","volume":"38","author":"Wilkie","year":"2020","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"673532","DOI":"10.3389\/fimmu.2021.673532","article-title":"A 2-Dose AERAS-402 Regimen Boosts CD8+ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients","volume":"12","author":"Sivakumaran","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1016\/j.vaccine.2014.09.001","article-title":"The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses","volume":"32","author":"Kagina","year":"2014","journal-title":"Vaccine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.vaccine.2009.01.132","article-title":"A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice","volume":"27","author":"Perera","year":"2009","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mt.2008.59","article-title":"Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine","volume":"16","author":"Roediger","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jamp.2015.1233","article-title":"Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure","volume":"29","author":"Liu","year":"2016","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"101128","DOI":"10.1128\/AAC.00871-19","article-title":"Prophylaxis of mycobacterium tuberculosis H37Rv infection in a preclinical mouse model via inhalation of nebulized bacteriophage D29","volume":"63","author":"Carrigy","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","unstructured":"Stukova, M. (2023, September 23). Randomized Open Label Phase 1 Clinical Trial of TB\/FLU-01L Tuberculosis Vaccine Administered Intranasally or Sublingual in BCG-Vaccinated Healthy Adults. Global Forum on TB Vaccines, New Delhi, India. Available online: https:\/\/tbvaccinesforum.org\/wp-content\/uploads\/2018\/03\/5GF-Breakout-2-Stukova.pdf."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Shurygina, A.P., Zabolotnykh, N., Vinogradova, T., Khairullin, B., Kassenov, M., Nurpeisova, A., Sarsenbayeva, G., Sansyzbay, A., Vasilyev, K., and Buzitskaya, J. (2023). Preclinical Evaluation of TB\/FLU-04L\u2014An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087439"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Belnoue, E., Vogelzang, A., Nieuwenhuizen, N.E., Krzyzaniak, M.A., Darbre, S., Kreutzfeldt, M., Wagner, I., Merkler, D., Lambert, P.H., and Kaufmann, S.H.E. (2022). Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052700"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/10\/1475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:07:56Z","timestamp":1760130476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/10\/1475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ph16101475"],"URL":"https:\/\/doi.org\/10.3390\/ph16101475","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}